Application 204325
- Type
- NDA
- Sponsor
- NEOS THERAPS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ADZENYS ER | AMPHETAMINE | SUSPENSION, EXTENDED RELEASE;ORAL | EQ 1.25MG BASE/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204325-001 | ADZENYS ER | AMPHETAMINE | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | |
| N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | |
| N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Adzenys XR-ODT | AMPHETAMINE | Neos Therapeutics Brands, LLC | c1179269-00b5-48ea-972d-31e614e99b7e | 2026-05-13 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE |
| Dyanavel XR | AMPHETAMINE | NextWave Pharmaceuticals, Inc | ae304b29-0b40-40ec-ad0d-76b742d4a9b9 | 2026-02-24 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE |
| Amphetamine Sulfate | AMPHETAMINE | Amneal Pharmaceuticals NY LLC | 53d40847-e0d3-48ec-81a7-ec5478553565 | 2025-10-01 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE |
| Amphetamine | AMPHETAMINE | Teva Pharmaceuticals, Inc. | 243e88e7-6621-47e9-8d5c-3f79bcb088bb | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | AMPHETAMINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 66993-360 | Amphetamine Extended-Release Oral Suspension | Amphetamine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-360 | Amphetamine Extended-Release Oral Suspension | Amphetamine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 70165-003 | Adzenys ER | Amphetamine | Neos Therapeutics, LP | NDA | Current |
| 70165-003 | Adzenys ER | Amphetamine | Neos Therapeutics, LP | NDA | Current |
| 70165-003 | Adzenys ER | Amphetamine | Neos Therapeutics Brands, LLC | NDA | Current |